Relapsed/Refractory T-cell Lymphoma
1 clinical trials · Condition
◉ Watch Relapsed/Refractory T-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| CD70-CAR-NK Cell Therapy for T Cell Lymphoma and Acute Myeloid Leukemia (NCT06696846) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2024-12-01 |
Track Relapsed/Refractory T-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.